Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Solid Carcinoma 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Lymphoma 1Lung Neoplasms 1Diarrhea 1Colitis 1Cachexia 1Breast Neoplasms 1

Interventions

Specimen Handling 613pembrolizumab 563Magnetic Resonance Spectroscopy 536Carboplatin 425Cisplatin 375Cyclophosphamide 373Biopsy 357Paclitaxel 306Gemcitabine 303Nivolumab 300Radiotherapy 260Bevacizumab 234Dexamethasone 209fludarabine 205Docetaxel 187durvalumab 182atezolizumab 173Oxaliplatin 172venetoclax 168Fluorouracil 166Rituximab 165Pemetrexed 163Capecitabine 158Doxorubicin 157Radiation 155Radiosurgery 148Etoposide 137Leucovorin 133Ipilimumab 133Lenalidomide 131

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Fecal Microbiota Transplantation × 90 days × Clear all
NCT04264975 2026-05-22

Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology

Asan Medical Center

Phase NA Recruiting
60 enrolled

Solid Carcinoma

NCT04975217 2026-05-22

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Suspended
10 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07533227 2026-04-16

FMT-CACH

Changzhou No.2 People's Hospital

Phase 2 Not yet recruiting
66 enrolled

Cachexia, Neoplasms

NCT06218602 2026-04-15

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

M.D. Anderson Cancer Center

Phase 2 Recruiting
40 enrolled
Lymphoid

Lymphoma

NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡